STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

COLL COLLEGIUM PHARMACEUTICALS INCORPORATED StockScouter® Report

5

StockScouter® Score

COLLEGIUM PHARMACEUTICALS INCORPORATED, a small cap value company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Short-term relative price momentum exhibits meaningful strength. Postive
  • One or more less experienced analysts has modestly increased quarterly earnings estimates for COLL. Positive/Neutral

 

Concerns

  • Earnings growth in the past year has decelerated rapidly compared to earnings growth in the past three years. Negative
  • The multi-period measure of relative price change and consistency is below average. Negative/Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, value stocks will be in favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 60% done.
Low
High

Core Model Grades

C
C
C
D

Previous Ratings

4
5
5